Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial
Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial. // eBioMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2352396426004317?dgcid=rss_sd_all
Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial. eBioMedicine. https://www.sciencedirect.com/science/article/pii/S2352396426004317?dgcid=rss_sd_all
“Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial.” eBioMedicine.
@article{article43640,
title = {Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial},
journal = {eBioMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2352396426004317?dgcid=rss_sd_all}
}